Scinai Immunotherapeutics (SCNI) Shares Outstanding (2014 - 2026)

Scinai Immunotherapeutics (SCNI) has 8 years of Shares Outstanding (Entity) data on file, last reported at $1.4 million in Q4 2021.

• For the quarter ending Q4 2021, Shares Outstanding (Entity) fell 87.26% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2021 stood at $1.4 million (down 87.26% YoY), and the FY2021 full-year result was $1.4 million, down 87.26% from the prior year.
• Shares Outstanding (Entity) fell to $1.4 million in Q4 2021, from $1.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $14.3 million in Q2 2021 to a low of $1.4 million in Q4 2021.
• A 5-year average of $7.5 million and a median of $6.5 million in 2018 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) jumped 60.89% in 2018 and plunged 87.57% in 2021, its largest moves.
• Tracing SCNI's Shares Outstanding (Entity) over 5 years: stood at $4.8 million in 2017, then soared by 36.5% to $6.5 million in 2018, then jumped by 44.56% to $9.4 million in 2019, then climbed by 17.3% to $11.1 million in 2020, then slumped by 87.26% to $1.4 million in 2021.
• Business Quant data shows SCNI's Shares Outstanding (Entity) at $1.4 million in Q4 2021, $1.4 million in Q3 2021, and $14.3 million in Q2 2021.